Analytical Data
-
Gene name
ZNF26
- Application
-
Alternative Names
Zinc finger protein KOX20
-
Species
Human
-
Source
E. coli
-
Tag
N- His-SUMO
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
P17031
-
Expression Region
335-533aa
-
Molecular Weight
38.6 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
ZNF26, a member of the zinc finger protein family, is known for its role in transcriptional regulation and gene expression. It contains multiple C2H2 zinc finger motifs, which are critical for DNA binding and interaction with other proteins. Recent studies have highlighted ZNF26's involvement in various cellular processes, including development, cell differentiation, and response to stress, suggesting its importance in maintaining cellular homeostasis. Furthermore, ZNF26 has been associated with several diseases, including certain cancers, where its expression levels may correlate with tumor progression and patient prognosis. Researchers are increasingly focused on the recombinant expression of ZNF26 to investigate its functional properties and therapeutic potential. By producing the protein in heterologous systems, scientists aim to elucidate its structural characteristics and interaction networks. This research could lead to a better understanding of ZNF26's mechanisms in regulating gene expression and its role in disease, potentially paving the way for novel diagnostic or therapeutic approaches that target ZNF26 or its pathways. The utilization of recombinant ZNF26 in functional assays and structural studies could provide insights into its biological significance and leverage its application in biotechnology and medicine.
